This work provides a systematic review of the literature from January 2003 to April 2014
pertaining to the incidence, pathophysiology, diagnosis, and treatment of osteonecrosis of …

Osteonecrosis of the jaw (ONJ) has been associated with antiresorptive therapy in both
oncology and osteoporosis patients. This debilitating condition is very rare and advances in …

PURPOSE: Osteonecrosis of the jaw (ONJ) is a serious complication associated with
bisphosphonate therapy, but its epidemiology in the setting of oral bisphosphonate therapy …

Purpose The reported incidence of osteonecrosis of the jaw (ONJ) ranges from 0.94% to
18.6%. This cohort study aimed to calculate the incidence of and identify the risk factors for …

The Society of Nuclear Medicine (SNM) is an international scientific and professional
organization founded in 1954 to promote the science, technology, and practical application …

Bisphosphonates (BPs) have been widely, efficiently, and safely used for the treatment of
osteoporosis, malignant hypercalcemia, bone metastasis of solid cancers, and multiple …

Purpose To investigate the role of oral health, including periodontitis, as a risk factor for
bisphosphonate-associated jaw osteonecrosis (ONJ). Materials and Methods This cross …

Osteonecrosis of the jaw (ONJ) can be associated with nitrogen-containing
bisphosphonates (NBPs) therapy. Various mechanisms of NBP-associated ONJ have been …

Multiple Myeloma (MM) is a hematologic malignancy characterized by the proliferation of
monoclonal plasma cells localized within the bone marrow. Bone disease with associated …

Necrotic bone exposure in the oral cavity has recently been reported in patients treated with
nitrogen‐containing bisphosphonates as part of their therapeutic regimen for multiple …